CN113101365A - Photodynamic nano platform with mitochondrion targeting characteristic and preparation method and application thereof - Google Patents

Photodynamic nano platform with mitochondrion targeting characteristic and preparation method and application thereof Download PDF

Info

Publication number
CN113101365A
CN113101365A CN202110335085.9A CN202110335085A CN113101365A CN 113101365 A CN113101365 A CN 113101365A CN 202110335085 A CN202110335085 A CN 202110335085A CN 113101365 A CN113101365 A CN 113101365A
Authority
CN
China
Prior art keywords
photodynamic
mitochondrial targeting
mesoporous
flexible
nanoplatform
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202110335085.9A
Other languages
Chinese (zh)
Inventor
滕兆刚
史文慧
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanjing University of Posts and Telecommunications
Original Assignee
Nanjing University of Posts and Telecommunications
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanjing University of Posts and Telecommunications filed Critical Nanjing University of Posts and Telecommunications
Priority to CN202110335085.9A priority Critical patent/CN113101365A/en
Publication of CN113101365A publication Critical patent/CN113101365A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y40/00Manufacture or treatment of nanostructures
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nanotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Manufacturing & Machinery (AREA)
  • General Physics & Mathematics (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

本发明属于光动力治疗技术领域,公开了一种具有线粒体靶向特性的光动力纳米平台及其制备方法和应用。线粒体靶向特性的光动力纳米平台由柔性介孔有机氧化硅、线粒体靶向分子和光敏剂构成,其具有皱缩的表面、较大的内部空腔以及介孔孔道,能够高效率装载药物并且具有高效细胞摄取特性。制备方法包括通过碱性溶液刻蚀获得柔性介孔有机氧化硅壳层,在其表面进行功能化修饰线粒体靶向分子与光敏剂Ce6。柔性介孔有机硅纳米颗粒结合了线粒体靶向功能,提高了细胞内吞噬效率、线粒体靶向能力和光动力治疗效果。本发明提供的制备方法简便易得,且得到的产物产率高,在肿瘤光动力治疗等领域具有巨大的应用潜力。

Figure 202110335085

The invention belongs to the technical field of photodynamic therapy, and discloses a photodynamic nano-platform with mitochondrial targeting properties and a preparation method and application thereof. The photodynamic nanoplatform with mitochondrial targeting properties is composed of flexible mesoporous organosilica, mitochondrial targeting molecules and photosensitizers. It has a shrunken surface, large internal cavity, and mesoporous pores, which can efficiently load drugs and Has high cellular uptake properties. The preparation method includes obtaining a flexible mesoporous organic silica shell layer by alkaline solution etching, and performing functional modification on the surface of mitochondrial targeting molecule and photosensitizer Ce6. Flexible mesoporous organosilicon nanoparticles combine mitochondria-targeting functions to enhance intracellular phagocytosis efficiency, mitochondria-targeting ability, and photodynamic therapy efficacy. The preparation method provided by the invention is simple and easy to obtain, and the obtained product has a high yield, and has great application potential in the fields of tumor photodynamic therapy and the like.

Figure 202110335085

Description

Photodynamic nano platform with mitochondrion targeting characteristic and preparation method and application thereof
Technical Field
The invention belongs to the technical field of photodynamic therapy, and particularly relates to a photodynamic nano platform with a mitochondrion targeting characteristic, and a preparation method and application thereof.
Background
Photodynamic therapy is an emerging tumor treatment following surgical resection, chemotherapy, and radiation therapy. Photodynamic therapy medicines, namely photosensitizers can selectively act on tumor parts, have the advantages of small wound, good repeatability, no accumulated toxicity, less adverse reaction and the like, and show more and more obvious advantages in tumor treatment. Despite the broad prospects for tumor therapy, the clinical application of conventional photodynamic therapy still has many disadvantages. Firstly, most of the photosensitizers are aromatic molecules which are poorly soluble in water and tend to aggregate, thus easily causing skin phototoxicity. On the other hand, the singlet oxygen generated by the photosensitizer has small action range and short service life, and can act when not reaching organelles, thereby greatly restricting the killing effect of the photosensitizer. To solve these problems, nano-support platforms are increasingly used.
In recent years, flexible mesoporous organosilica nanomaterials have received extensive attention from biomedicine due to their material properties and special mechanical characteristics. As a nano-carrier platform, the mesoporous organic silicon oxide nano-particles have the characteristics of adjustable mesoporous structure, large specific surface area, good dispersibility, uniform size, biodegradability, high biocompatibility and the like, and become ideal carriers of various molecular imaging probes and anticancer therapeutic drugs. In the design of nanoparticles, mechanical properties play an important role. The flexibility is taken as an important mechanical property of the nano particles, and plays an important role in various biological processes such as blood circulation, tumor tissue infiltration, cell internalization and metabolism. However, the flexible organic silicon oxide nanoparticles have single function as a nano-drug carrier, so that the tumor treatment effect is difficult to achieve, and the characteristics of mitochondria targeting and photodynamic therapy are combined, so that the flexible mesoporous organic silicon oxide nanoparticles are widely researched in biomedical application, but more new applications are still to be explored.
Disclosure of Invention
The invention aims to provide a preparation method of a flexible mesoporous organic silicon oxide nano delivery platform loaded with carboxyl triphenyl phosphorus (CTPP) and a photosensitizer ce 6. The nano platform enhances the intratumoral uptake and simultaneously improves the loading efficiency of Ce6, and in addition, the mitochondrial targeting effect of triphenylphosphine further improves the killing efficiency of Ce6 cells. Based on the basic characteristics of flexible mesoporous silica and photodynamic therapy, the invention provides a preparation method of a flexible mesoporous organic silica nano delivery platform and a method for loading triphenylphosphine and a photosensitizer ce 6. The accumulation in the tumor is improved, and the mitochondria are targeted, so that the photodynamic treatment effect is further enhanced.
The invention is realized by the following technical scheme:
a photodynamic nano platform with a mitochondrion targeting characteristic comprises flexible mesoporous organic silicon oxide, mitochondrion targeting molecules and a photosensitizer.
Further, the mitochondrion targeting molecule is triphenylphosphine.
Further, the photosensitizer is Ce 6.
Furthermore, the flexible mesoporous organic silicon oxide shell is doped with disulfide bonds.
Furthermore, the thickness of the flexible mesoporous organic silicon oxide shell layer is 20-30 nm.
A preparation method of a photodynamic nano platform with a mitochondrion targeting characteristic comprises the steps of synthesizing mesoporous organic silicon oxide containing a disulfide bond by using an organic silicon source, breaking the disulfide bond to connect amino to obtain aminated nano particles, modifying triphenyl phosphorus and a photosensitizer Ce6 on the surfaces of the aminated nano particles together to obtain mesoporous organic silicon oxide nano particles with CTPP and Ce6, and etching the mesoporous organic silicon oxide nano particles in an alkaline solution to form high tumor uptake to obtain the photodynamic flexible nano platform with the mitochondrion targeting function.
Further, in the process of synthesizing the mesoporous organic silicon oxide containing disulfide bonds, an organic silicon source with disulfide bonds is doped in the flexible mesoporous organic silicon oxide shell, the disulfide bonds are broken under the conditions of 40 ℃ and 800rpm and N2 full filling, and the amino groups of the maleamide are connected to obtain the aminated nanoparticles.
Further, after the mesoporous organic silicon oxide nanoparticles modified with CTPP and Ce6 are centrifuged, adding alkali liquor, placing the mixture in a shaking table for 10-20 min, and washing the mixture for 2-4 times to obtain flexible mesoporous organic nanoparticles, wherein the flexible mesoporous organic nanoparticles are dispersed in ethanol.
Furthermore, the organic silicon source is TETS and TEOS, and the volume ratio of TETS to TEOS is 1: 2-3.
The invention also provides application of the photodynamic nano platform with the mitochondrion targeting characteristic in preparing antitumor drugs.
A preparation method of a photodynamic nano platform with a mitochondrion targeting characteristic comprises the following steps:
(1) synthesis of organosilica nanoparticles (MONs): adding 0.16g of hexadecyl trimethyl ammonium bromide (CTAB) into 30ml of ethanol and 75ml of deionized water, adding 1ml of ammonia water, reacting for 1 hour at 35 ℃ and at the rotating speed of 1100rpm, adding 0.1ml of 1, 3-ethoxy silicon-based tetrasulfide (TETS) and 0.25ml of tetraethyl orthosilicate (TEOS) which are mixed with a silicon source, reacting for 24 hours, and centrifuging and washing for 3 times to obtain organic silicon oxide nanoparticles;
(2) surface-modified amino group: first, the disulfide bond was cleaved by adding 2.4ml of water, 8.8ml of dioxane, 0.4g of triphenylphosphine and 160. mu.l of concentrated hydrochloric acid to a sample, and reacting for 2 hours at 40 ℃ and 800rpm filled with N2. After 4mg of maleimido amino group was added to the disulfide-bond-cleaved sample, the reaction was carried out for 12 hours, and centrifuged and washed 3 times.
(3) Activating carboxyl and connecting: first, 1ml of carboxytriphenylphosphine CTPP (20mg/ml), 1ml of the photosensitizer Ce6(20mg/ml) were mixed with 0.5ml of bis [3- (triethoxysilyl) propyl ] tetrasulfide EDC (20mg/ml in N, N-Dimethylformamide (DMF)) and 0.5ml of N-hydroxysuccinimide NHS (20mg/ml in DMF), respectively. The mixture was shaken at room temperature for 3 hours to activate the carboxyl group. Then 1ml of nanoparticles were dispersed into the carboxy-activated CTPP solution. After 12h of reaction, centrifugal washing is carried out for 3 times, and the mixture is dispersed into Ce6 activated by carboxyl, and the stable MONs-CTPP-Ce6 modified by surface function is obtained after 12h of reaction and 3 times of centrifugal washing.
(4) Synthetic flexible organosilica nanoparticles (SMONs-CTPP-Ce 6): centrifuging 2mg MONs-CTPP-Ce6 with modified surface at 10000rpm, dispersing in 1ml water, adding 100 μ L1M NaOH solution, placing in a shaking table for 15min, washing with water for 3 times to obtain flexible mesoporous organic nanoparticles (SMONs-CTPP-Ce6), and dispersing in ethanol.
Advantageous effects
1. The mesoporous organic silicon oxide has rich mesopores, and the photodynamic nano platform provided by the invention has a shrunken surface, a larger internal cavity and a mesoporous pore channel, can be used for loading the drug with high efficiency, has the characteristic of high-efficiency cell uptake, and is beneficial to loading and transporting the drug;
2. the flexible mesoporous organic silicon oxide nano-particles are prepared by an alkaline solution etching method, the requirements on equipment in the process are low, the cost is low, and the environment is friendly; the preparation method provided by the invention is simple and easy to obtain, and the obtained product has high yield and great application potential in the fields of tumor photodynamic therapy and the like;
3. the flexible material has more excellent in vivo circulation and tumor uptake capacity;
4. after the surface modification is finished, the mitochondrion targeting obviously improves the curative effect of photodynamic therapy; the flexible mesoporous organic silicon nano-particles combine the mitochondrion targeting function, and improve the endocytosis efficiency, the mitochondrion targeting capability and the photodynamic treatment effect of cells.
Drawings
FIG. 1 is a structural formula of a photosensitizer Ce 6;
FIG. 2 is a structural formula of Carboxytriphenylphosphonium (CTPP);
fig. 3 is a working principle of the preparation and synthesis of the mesoporous organic silicon oxide nano platform and the preparation method of the supported photosensitizer Ce6 and Carboxyl Triphenylphosphine (CTPP) in embodiment 1 of the present invention;
FIG. 4 is a Scanning Electron Microscope (SEM) and a Transmission Electron Microscope (TEM) representation of the prepared flexible mesoporous silica nanoparticles in example 1 of the present invention;
FIG. 5 is a high-power transmission electron microscope bright field and element distribution image of the prepared flexible mesoporous silica nanoparticles in example 1 of the present invention;
FIG. 6 is a potential diagram and an ultraviolet absorption spectrum diagram of the flexible mesoporous silica nanoparticles prepared in example 1 according to the present invention at different loading stages;
FIG. 7 is a cytocompatibility chart of the surface-modified flexible mesoporous silica nanoparticles prepared in example 1 of the present invention;
fig. 8 is a comparative graph of targeted photodynamic therapy of the prepared surface-modified flexible mesoporous silica nanoparticles in example 1 of the present invention.
Detailed Description
In order to make those skilled in the art better understand the technical solution of the present invention, the following further describes the technical solution of the present invention with reference to the drawings and the embodiments.
With reference to fig. 1, 2 and 3, a preparation method of a flexible mesoporous organosilica nano-delivery platform loaded with CTPP and a photosensitizer ce6 is specifically described.
Example 1: synthesis of Mesoporous Organosilica Nanoparticles (MONs):
all synthetic experiments are completed in a water bath kettle; first, 75ml of deionized water, 30ml of ethanol, 1ml of concentrated ammonia water and 0.16g of cetyltrimethylammonium bromide were sequentially added to a reaction flask, stirred at 1100rpm for 1 hour at 35 ℃, and then a mixed solution of 0.25ml of TEOS and 0.1ml of TETS was added to the above reaction flask, and stirring was continued for 24 hours to obtain a white suspension, which was separated and washed 3 times with ethanol. Dispersing the obtained nano particles in a mixed solution of 120ml of ethanol and 240 mul of concentrated hydrochloric acid, and heating for 12h at the temperature of 60 ℃ to remove the surfactant, thereby finally obtaining the mesoporous organic silicon oxide nano particles.
Example 2
Surface modification: it is necessary to modify the surface of the particles with amino groups and then to react with the carboxyl groups CTPP and Ce 6.
First, disulfide bond cleavage: washing 10 mg of nano material with deionized water, dispersing in a mixed solution of 1.2ml of deionized water and 4.4ml of dioxane, adding 0.19 g of triphenylphosphine and 80 μ l of concentrated hydrochloric acid, ultrasonically mixing for 10min, placing in a water bath, reacting for two hours at 40 ℃ and 800rpm in a nitrogen environment, washing once with alcohol, and washing twice with water.
In the second step, the treated sample was dispersed in 1.2ml of water, 0.12ml of DMF and 4mg of NH2-MAL, respectively, reacted for 12 hours, washed three times with deionized water, and then dispersed in 1ml of water.
In the third step, CTPP was activated and attached to the carboxyl group of ce 6. First, 1ml of CTPP (20mg/ml), 1ml of ce6(20mg/ml) were mixed with 0.5ml of EDC (20mg/ml in DMF) and 0.5ml of NHS (20mg/ml in DMF), respectively. The mixture was shaken at room temperature for 3 hours to activate the carboxyl group. Then 1ml of nanoparticles were dispersed into the carboxy-activated CTPP solution. After 12h of reaction, centrifugal washing is carried out for 3 times, and the mixture is dispersed into Ce6 activated by carboxyl, and the stable MONs-CTPP-Ce6 modified by surface function is obtained after 12h of reaction and 3 times of centrifugal washing.
Example 3
Preparation of Flexible MONs-CTPP-Ce6
Centrifuging 2mg MONs-CTPP-Ce6 with modified surface at 10000rpm, dispersing in 1ml water, adding 100 μ L of 1M NaOH solution, placing in a shaking table for 15min, washing with water for 3 times to obtain flexible mesoporous organic nanoparticles (SMONs-CTPP-Ce6), and dispersing in ethanol.
FIGS. 4 a-c, the resulting SMONs-CTPP-Ce6 nanoparticles were observed using Scanning Electron Microscopy (SEM) and Transmission Electron Microscopy (TEM). The flexible nanoparticles had good dispersibility, were uniform in size, had a particle size of about 200nm, and significant surface shrinkage was observed, with a silicon layer thickness of about 25 nm.
Fig. 5 d-f are high-power transmission electron microscope bright field and element distribution images of the flexible mesoporous organosilicon nanoparticles, and the element distribution images show that phosphorus is uniformly distributed on the surfaces of the flexible mesoporous organosilicon nanoparticles.
Fig. 6a shows the potential change in different loading processes, the surface modified amino group, CTPP and Ce6 have obvious positive-negative conversion, and the potential does not change after the particle etching, indicating that the modified molecules are stably connected.
FIG. 6b shows UV testing of free Ce6 and SMONs-CTPP-Ce6, since free Ce6 shows a distinct absorption peak at 660nm, while SMONs-CTPP-Ce6 shows the same peak, indicating successful loading of photosensitizer Ce 6.
FIG. 7 shows that SMONs-CTPP-Ce6 is used as a biocompatibility test, mouse breast cancer cells (4T1 cells) are selected for experiments, the concentration is 0-1000 mug/l, the cell activity reaches more than 80%, and the nanoparticles are proved to have good biocompatibility.
Fig. 8 is a graph showing the photodynamic effect of SMONs-CTPP-Ce6, and the cell activities of the three experimental groups gradually decreased with the increase of the concentration of the photosensitizer Ce6, and when the concentration of Ce6 reached 20 μm/ml, the SMONs-CTPP-Ce6 had a greater killing efficiency and the cell survival rate was 1/2 and less than 20% of that of the control group of free Ce6, compared with the control group of no mitochondrial targeting and free Ce 6.
The above experiments describe the basic principles, main features and advantages of the present invention. However, the above description is only an example of the present invention, the technical features of the present invention are not limited thereto, and any other embodiments that can be obtained by those skilled in the art without departing from the technical solution of the present invention should be covered by the claims of the present invention.

Claims (10)

1.一种具有线粒体靶向特性的光动力纳米平台,其特征在于,所述光动力纳米平台包括柔性介孔有机氧化硅、线粒体靶向分子和光敏剂。1. A photodynamic nanoplatform with mitochondrial targeting characteristics, characterized in that, the photodynamic nanoplatform comprises flexible mesoporous organosilica, mitochondrial targeting molecule and photosensitizer. 2.根据权利要求1所述的具有线粒体靶向特性的光动力纳米平台,其特征在于,所述线粒体靶向分子为三苯基磷。2 . The photodynamic nano-platform with mitochondrial targeting properties according to claim 1 , wherein the mitochondrial targeting molecule is triphenylphosphine. 3 . 3.根据权利要求1所述的具有线粒体靶向特性的光动力纳米平台,其特征在于,所述光敏剂为Ce6。3. The photodynamic nanoplatform with mitochondrial targeting properties according to claim 1, wherein the photosensitizer is Ce6. 4.根据权利要求1所述的具有线粒体靶向特性的光动力纳米平台,其特征在于,柔性介孔有机氧化硅外壳中掺杂有二硫键。4 . The photodynamic nanoplatform with mitochondrial targeting properties according to claim 1 , wherein the flexible mesoporous organosilica shell is doped with disulfide bonds. 5 . 5.根据权利要求1所述的具有线粒体靶向特性的光动力纳米平台,其特征在于,柔性介孔有机氧化硅壳层的厚度为20~30nm。5 . The photodynamic nanoplatform with mitochondrial targeting properties according to claim 1 , wherein the thickness of the flexible mesoporous organosilica shell layer is 20-30 nm. 6 . 6.根据权利要求1~5任一项所述的具有线粒体靶向特性的光动力纳米平台的制备方法,其特征在于,使用有机硅源合成含有二硫键的介孔有机氧化硅,断开二硫键连接氨基得到氨基化纳米颗粒,并在氨基化纳米颗粒表面共同修饰三苯基磷及光敏剂Ce6,得到修饰了CTPP和Ce6的介孔有机氧化硅纳米颗粒,在碱性溶液中刻蚀后形成肿瘤高摄取,得到具有线粒体靶向功能的光动力柔性纳米平台。6. The method for preparing a photodynamic nanoplatform with mitochondrial targeting properties according to any one of claims 1 to 5, characterized in that, using an organosilicon source to synthesize mesoporous organosilicon containing disulfide bonds, disconnecting Aminated nanoparticles were obtained by connecting amino groups with disulfide bonds, and triphenylphosphorus and photosensitizer Ce6 were co-modified on the surface of the aminated nanoparticles to obtain mesoporous organosilica nanoparticles modified with CTPP and Ce6. After etched, high tumor uptake was formed, and a photodynamic flexible nanoplatform with mitochondrial targeting function was obtained. 7.根据权利要求6所述的具有线粒体靶向特性的光动力纳米平台的制备方法,其特征在于,合成含有二硫键的介孔有机氧化硅过程中,在柔性介孔有机氧化硅外壳中掺杂带有二硫键的有机硅源,在40℃,800rpm,充满N2的条件下断开二硫键,连接马来酰胺氨基,得到氨基化纳米颗粒。7. The method for preparing a photodynamic nanoplatform with mitochondrial targeting characteristics according to claim 6, wherein in the process of synthesizing the mesoporous organosilicon containing disulfide bonds, in the flexible mesoporous organosilicon shell Doping an organosilicon source with a disulfide bond, breaking the disulfide bond at 40 °C, 800 rpm, filled with N2 , and connecting the maleamido amino group to obtain aminated nanoparticles. 8.根据权利要求6所述的具有线粒体靶向特性的光动力纳米平台的制备方法,其特征在于,修饰了CTPP和Ce6的介孔有机氧化硅纳米颗粒离心后加入碱液置于摇床10~20min,水洗2~4次,得到柔性介孔有机纳米颗粒,分散于乙醇中。8. the preparation method of the photodynamic nano-platform with mitochondrial targeting characteristic according to claim 6, is characterized in that, after the mesoporous organosilica nanoparticle of modified CTPP and Ce6 is centrifuged, adds lye and is placed in shaking table 10 . ~20min, washed 2~4 times with water to obtain flexible mesoporous organic nanoparticles, which were dispersed in ethanol. 9.根据权利要求6所述的具有线粒体靶向特性的光动力纳米平台的制备方法,其特征在于,所述有机硅源为TETS和TEOS,TETS和TEOS的体积比为1:2~3。9 . The method for preparing a photodynamic nanoplatform with mitochondrial targeting properties according to claim 6 , wherein the organosilicon source is TETS and TEOS, and the volume ratio of TETS and TEOS is 1:2-3. 10 . 10.根据权利要求1~5任一项所述的具有线粒体靶向特性的光动力纳米平台在制备抗肿瘤药物中的应用。10 . The application of the photodynamic nanoplatform with mitochondrial targeting properties according to any one of claims 1 to 5 in the preparation of antitumor drugs. 11 .
CN202110335085.9A 2021-03-29 2021-03-29 Photodynamic nano platform with mitochondrion targeting characteristic and preparation method and application thereof Pending CN113101365A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110335085.9A CN113101365A (en) 2021-03-29 2021-03-29 Photodynamic nano platform with mitochondrion targeting characteristic and preparation method and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110335085.9A CN113101365A (en) 2021-03-29 2021-03-29 Photodynamic nano platform with mitochondrion targeting characteristic and preparation method and application thereof

Publications (1)

Publication Number Publication Date
CN113101365A true CN113101365A (en) 2021-07-13

Family

ID=76712569

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110335085.9A Pending CN113101365A (en) 2021-03-29 2021-03-29 Photodynamic nano platform with mitochondrion targeting characteristic and preparation method and application thereof

Country Status (1)

Country Link
CN (1) CN113101365A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114344464A (en) * 2021-12-17 2022-04-15 南京邮电大学 Self-carrying oxygen-carrying mitochondria-targeted photodynamic therapy nanoplatform, preparation method and application
CN114948926A (en) * 2022-05-24 2022-08-30 浙江大学医学院附属第一医院 Mitochondrion-targeted cabazitaxel prodrug and preparation method and application thereof
CN116350792A (en) * 2023-03-16 2023-06-30 南京邮电大学 A flexible nanomotor constructed of mesoporous organosilica material and its preparation method and application

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107019802A (en) * 2017-03-22 2017-08-08 南京邮电大学 A kind of flexible hollow mesoporous organic silicon oxide nanometer capsule material and preparation method
CN108066765A (en) * 2016-11-17 2018-05-25 中国科学院大连化学物理研究所 Mitochondrially targeted silicon Nano medication delivery vector prepares and carrier application
CN109395079A (en) * 2018-10-17 2019-03-01 中国人民解放军南京军区南京总医院 A kind of multifunctional nano probe and its preparation method and application
CN109771666A (en) * 2019-03-27 2019-05-21 南京邮电大学 A flexible mesoporous organosilicon nanorod and its preparation method and application
CN110623943A (en) * 2019-11-14 2019-12-31 吉林大学第一医院 Drug-loading application of a flexible hollow mesoporous organosilica

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108066765A (en) * 2016-11-17 2018-05-25 中国科学院大连化学物理研究所 Mitochondrially targeted silicon Nano medication delivery vector prepares and carrier application
CN107019802A (en) * 2017-03-22 2017-08-08 南京邮电大学 A kind of flexible hollow mesoporous organic silicon oxide nanometer capsule material and preparation method
CN109395079A (en) * 2018-10-17 2019-03-01 中国人民解放军南京军区南京总医院 A kind of multifunctional nano probe and its preparation method and application
CN109771666A (en) * 2019-03-27 2019-05-21 南京邮电大学 A flexible mesoporous organosilicon nanorod and its preparation method and application
CN110623943A (en) * 2019-11-14 2019-12-31 吉林大学第一医院 Drug-loading application of a flexible hollow mesoporous organosilica

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
GUANGBAO YANG ET AL: "Mesoporous silica nanorods intrinsically doped with photosensitizers as a multifunctional drug carrier for combination therapy of cancer", 《NANO RESEARCH》 *
XIAOLI CAI ET AL: "Integrating in situ formation of nanozymes with three-dimensional dendritic mesoporous silica nanospheres for hypoxia-overcoming photodynamic therapy Check for updates", 《NANOSCALE》 *
YANJIAO LI ET AL: "Small size mesoporous organosilica nanorods with different aspect ratios:Synthesis and cellular uptake", 《JOURNAL OF COLLOID AND INTERFACE SCIENCE》 *
ZHAOGANG TENG ET AL: "Deformable Hollow Periodic Mesoporous Organosilica Nanocapsules for Significantly Improved Cellular Uptake", 《JOURNAL OF THE AMERICAN CHEMICAL SOCIETY》 *
ZHAOGANGTENG ET AL: "A Facile Multi-interface Transformation Approach to Monodisperse Multiple-Shelled Periodic Mesoporous Organosilica Hollow Spheres", 《JOURNAL OF THE AMERICAN CHEMICAL SOCIETY》 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114344464A (en) * 2021-12-17 2022-04-15 南京邮电大学 Self-carrying oxygen-carrying mitochondria-targeted photodynamic therapy nanoplatform, preparation method and application
CN114344464B (en) * 2021-12-17 2023-09-12 南京邮电大学 Self-carrying oxygen mitochondria-targeted photodynamic therapy nanoplatform, preparation method and application
CN114948926A (en) * 2022-05-24 2022-08-30 浙江大学医学院附属第一医院 Mitochondrion-targeted cabazitaxel prodrug and preparation method and application thereof
CN116350792A (en) * 2023-03-16 2023-06-30 南京邮电大学 A flexible nanomotor constructed of mesoporous organosilica material and its preparation method and application

Similar Documents

Publication Publication Date Title
Wang et al. Degradable carbon–silica nanocomposite with immunoadjuvant property for dual-modality photothermal/photodynamic therapy
CN113101365A (en) Photodynamic nano platform with mitochondrion targeting characteristic and preparation method and application thereof
Hakeem et al. Cellulose conjugated FITC-labelled mesoporous silica nanoparticles: intracellular accumulation and stimuli responsive doxorubicin release
CN109010850B (en) Preparation method and application of a curcumin-loaded dextran-modified gadolinium-doped hollow mesoporous silica nanomaterial
CN110538329A (en) A preparation method of pH-responsive mesoporous silica nano-drug carrier for three-in-one therapy
JP4991563B2 (en) Dosage form in which hydrophobic anticancer agent is encapsulated inside bile acid-chitosan complex and method for producing the same
CN104491886A (en) Preparation method of meso-porous silicon nanoparticle with reducing/enzyme dual response and targeting property
CN108014346A (en) A kind of preparation method of methotrexate (MTX) prodrug and its double targeted nano-particles
CN114159560A (en) Preparation method and application of GSH (glutathione-phosphate) and PH dual-response chemotherapy and photothermal combined treatment drug delivery carrier
CN113941009A (en) A kind of metal organic framework nanocarrier and its preparation method and application
Wu et al. Endogenous NO-release multi-responsive hollow mesoporous silica nanoparticles for drug encapsulation and delivery
CN111603436B (en) Photodynamic silica nanomaterial @ hydrogel composite drug loading system, and preparation method and application thereof
Lin et al. Tailoring nanoparticles based on boron dipyrromethene for cancer imaging and therapy
Li et al. ROS-responsive targeting micelles for optical imaging-guided chemo-phototherapy of cancer
CN114306636A (en) A kind of photoresponsive silica material, preparation method and application thereof
He et al. Nanomedicine-based multimodal therapies: Recent progress and perspectives in colon cancer
Hong et al. Polyethylene glycol-modified mesoporous polydopamine nanoparticles co-loaded with dimethylcurcumin and indocyanine green for combination therapy of castration-resistant prostate cancer
Zhu et al. A convergent fabrication of pH and redox dual-responsive hybrids of mesoporous silica nanoparticles for the treatment of breast cancer
CN103845743A (en) Gold particle-loaded silica multi-mode contrast agent and high intensity focused ultrasound (HIFU) synergist
CN114177286A (en) Injectable self-healing hydrogel encapsulated with mesoporous nano-microspheres, preparation method and application thereof
CN113599517A (en) Response type taxol dimer and photosensitizer co-assembled nano targeting drug delivery system and preparation method thereof
Lan et al. Chemo-photodynamic antitumour therapy based on Er-doped upconversion nanoparticles coated with hypocrellin B and MnO2
Li et al. Facile synthesis of triple-hybrid organosilica/manganese dioxide hybrid nanoparticles for glutathione-adaptive shape-morphing and improving cellular drug delivery
CN114344464B (en) Self-carrying oxygen mitochondria-targeted photodynamic therapy nanoplatform, preparation method and application
CN112891555B (en) A conjugate of hydroxyethyl starch grafted with chlorin e6, its preparation and application

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20210713

RJ01 Rejection of invention patent application after publication